Fate Therapeutics (FATE) Prices 8.6M Share Offering at $17.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
After-Hours Movers 09/11: (REVG) (CHGG) (BLKB) Higher; (TLRD) (CELP) (OXM) Lower (more...)
September 11, 2019 5:50 PM EDTToday's After-Hours Movers
Tailored Brands (NYSE: TLRD) 25.4% LOWER; reported Q2 EPS of $0.82, $0.08 better than the analyst estimate of $0.74. Revenue for the quarter came in at $789.5 million versus the consensus estimate of $789.19 million. Tailored Brands sees Q3 2019 EPS of $0.40-$0.45, versus the consensus of $0.88. Tailored Brands to suspends quarterly cash dividend starting in Q4 2019. Company to redeploy capital to accelerated debt repayment and share repurchases.
Celsius Holdings,... More
Fate Therapeutics (FATE) Plans Offering of Common Stock
September 11, 2019 4:02 PM EDTFate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that it has commenced an underwritten public offering of its common stock. Fate Therapeutics intends to use the net proceeds from the offering to fund... More
